A Tight A1c That Stopped Being Good News
Her A1c has been called excellent for years. At 86, with a shrinking appetite and three hypoglycemic episodes in two months, the same number has quietly become the more dangerous one in the room.
Eleanor W., an 86-year-old woman, has lived in an assisted-living apartment for the past three years, still hosts a Tuesday-afternoon bridge game in the community room, and by her own account has lost interest in "half of what used to be on her plate" over the past several months — not a deliberate diet change, just a shrinking appetite she attributes to getting older. She has had type 2 diabetes for over twenty years, on a basal-bolus insulin regimen with an A1c that has run a tight 6.9% for the past several checks, a number her longtime primary care physician once celebrated as excellent control. In the past two months, her visiting nurse has documented three episodes of blood glucose under 60 mg/dL, one of which left her too shaky to finish her own lunch.
Her daughter, who manages most of her mother's medical decisions and sat in on today's visit, pushed back hard when deintensification was raised: "if we cut back on the insulin, isn't her diabetes going to get worse?" It's a reasonable question on its face, and one the numbers themselves don't obviously answer for a family used to thinking of a lower A1c as simply better. What the numbers do show, read against her actual trajectory rather than against a younger patient's target, is a regimen that was set for a different Eleanor several years ago and never formally revisited as her appetite, weight, and overall frailty changed underneath it — a tight target that has become, at 86 with a shrinking appetite, more dangerous than the hyperglycemia it was designed to prevent.
A number that used to mean good control
This regimen needs to come down, and soon. She meets the frailty and reduced-life-expectancy criteria that the ADA and the American Geriatrics Society both use to justify a relaxed A1c target, in the 8–8.5% range rather than her current 6.9%. Three hypoglycemic episodes in two months isn't a warning sign, it's an ongoing harm — and at her age, a fall or a confusion episode from hypoglycemia carries real downstream risk that hyperglycemia in this range simply doesn't.
I agree with the direction, not with doing it all at once. A large across-the-board cut risks overshooting into rebound hyperglycemia, and it doesn't tell us which part of her regimen is actually causing the lows — her declining renal function affects insulin clearance broadly, but her reduced appetite specifically points at mealtime dosing outpacing what she's actually eating now.
I'd reduce the mealtime insulin first, by roughly a third, and hold the basal dose steady initially — if the hypoglycemia resolves, that tells us where the real problem was. Cutting everything at once erases that information.
Before either dosing plan goes home with her, I want to spend real time with her daughter on why we're doing this, because "we're cutting back" and "we're protecting her from a more dangerous risk than the one she's used to worrying about" land completely differently in that conversation.
I've known this family a long time, and a plan the daughter doesn't understand or trust doesn't reliably survive the trip home — she manages the medication log, and if she's quietly giving extra insulin because she's still scared of high numbers, we've solved nothing. I'd rather spend fifteen minutes on that conversation today than have this exact problem again next month.
Mealtime insulin reduced by roughly one-third, basal dose held steady, and a relaxed A1c target of 8–8.5% documented in her chart. Fifteen minutes were spent with the daughter directly, reframing the change as reducing an active, ongoing danger rather than loosening care — she left the visit saying she understood, though the team noted this is a conversation likely worth revisiting, not a one-time fix.
Not agreed: whether basal insulin should be reduced preemptively at the two-week follow-up regardless of what the mealtime change shows, given her declining renal function will keep affecting clearance either way. The endocrinologist wanted to wait for real data; the geriatrician would have cut both simultaneously given how clearly she already meets deintensification criteria. Left for the follow-up visit to settle.